Cargando…
Mesenchymal stem cell research progress for the treatment of COVID-19
At the end of 2019, novel coronavirus (COVID-19) infection was detected in Wuhan City, Hubei Province, China. The COVID-19 infection characteristics include a long incubation period, strong infectivity, and high fatality rate, and it negatively affects human health and social development. COVID-19 h...
Autores principales: | Yao, Dezhi, Ye, Huanrong, Huo, Zhirong, Wu, Lei, Wei, Shixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522503/ https://www.ncbi.nlm.nih.gov/pubmed/32972277 http://dx.doi.org/10.1177/0300060520955063 |
Ejemplares similares
-
Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications
por: Zhang, Jiarui, et al.
Publicado: (2023) -
Mesenchymal Stem Cells in the Treatment of COVID-19
por: Guo, Bei-Cyuan, et al.
Publicado: (2023) -
Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease
por: Gentile, Pietro, et al.
Publicado: (2020) -
Mesenchymal stem cell treatment for COVID-19
por: Xu, Ruonan, et al.
Publicado: (2022) -
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
por: Shu, Lei, et al.
Publicado: (2020)